Emerging manufacturing leader in cardiovascular and interventional devices leverages its clinical knowledge assets with clinivation Registry Suite. Framingham, MA, September 30, 2005 – clinivation, Inc. announced today that Bolton Medical, Inc. has selected clinivation Registry Suite™ software. “Bolton is clearly…
Emerging leader in diagnostic testing accelerates growth and product launch with clinivation’s Integrated Approval and Quality solutions. Framingham, MA, June 20, 2005 – clinivation, Inc. announced today that SDS, Inc. (NASDAQ: SVAD.OB) has selected clinivation’s integrated approval and quality systems…
World leader in dental and oral reconstruction products selects Global 2.0 to manage its medical products approvals and submissions worldwide. Framingham, MA, June 10, 2005 – clinivation, Inc. announced today that Implant Innovations, Inc. (3i) has selected clinivation Global™ 2.0…
Emerging leader in chronic pain and neurological medical devices selects Global 2.0 to manage its medical device approvals and submissions worldwide. Framingham, MA, June 9, 2005 – clinivation, Inc. announced today that ANS, Advanced Neuromodulation Systems, Inc. (NASDAQ NM: ANSI)…
Worldwide leader dedicated to less-invasive medicine selects clinivation’s Design Assurance solutions. Framingham, MA, June 8, 2005 – clinivation, Inc. announced today that Boston Scientific (NYSE: BSX) has selected clinivation’s design assurance solutions. “Boston Scientific is clearly a worldwide leader in…
Industry leader in application integration partners with clinivation to enable rapid integration of clinivation Global software with ERP and CM systems. Framingham, MA, May 10, 2005 – clinivation, Inc. announced today a partnership with InterSystems Corporation to enable rapid integration…
Company positions for sustainable growth and additional infrastructure, management, and staff appointments. Framingham, MA, April 11, 2005 – clinivation, Inc. today announced the expansion of its U.S. operations and infrastructure, and the appointment of senior executives in enterprise software and…
Dr. Joseph Kozikowski will present on the use of transdermal sustained delivery oxygen therapy for diabetic foot ulcers at regional wound care meeting. FRAMINGHAM, MA – April 1, 2005 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph…
Dr. Joseph Kozikowski will present on the use of nanoscale molecular imaging in breast cancer at GE Medical Systems European headquarters. FRAMINGHAM, MA – March 5, 2005 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D.…
Dr. Joseph Kozikowski will present on the use of nanoscale molecular imaging in breast cancer at Europe’s largest oncology research institute and teaching hospital. FRAMINGHAM, MA – March 3, 2005 – Clinivation, Inc. announced today that clinivation Founder and CEO…
Dr. Joseph Kozikowski will present on the use of nanoscale molecular imaging in breast cancer at leading Italian research institute and teaching hospital. FRAMINGHAM, MA – March 2, 2005 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph…
Company sustains high growth and profitability as biomedical industry adoption of solutions accelerates. Framingham, MA, January 20, 2005 – clinivation, Inc. today announced record year-end revenue, growth, and profitability results for 2004. “We are pleased to have achieved yet another…